Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Woman Killed in Pedestrian Crash at Mariposa and R Streets


Victim Hit by Car in Fatal Fresno Accident

Pedestrian Fatality 2
Pedestrian Fatality 2

Fresno, CA (March 11, 2020) – A woman was killed in a pedestrian crash in Fresno. The fatal accident occurred on the morning of March 11 at Mariposa and R streets.

A woman was crossing the intersection when she was hit by a car heading south on R Street. The woman was taken to a local hospital, where she later died.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Fresno

#93721


December 12, 2019

Man Killed in Train Crash at Farmdale Avenue and West Exposition Boulevard

Victim Falls Onto Tracks in Fatal Los Angeles Accident...


November 19, 2019

Man Killed in Crash at Highway 46 East and Buena Vista Road

2 Vehicles Involved in Fatal Paso Robles Accident...


May 5, 2020

Man Killed in Crash on Highway 101 Near Buena Vista Avenue

Driver Loses Control in Fatal Gilroy Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.